All Posts By

Smartkarma Daily Briefs

Daily Brief China: I-Mab and more

By | China, Daily Briefs

In today’s briefing:

  • I-Mab (IMAB.US) – An “Entertaining Bet”: To Be a Dark Horse or to Fail Completely

I-Mab (IMAB.US) – An “Entertaining Bet”: To Be a Dark Horse or to Fail Completely

By Xinyao (Criss) Wang

  • Many people aren’t optimistic about CD47 because there is no sufficient evidence to solve blood toxicity. Although I-MAB’s problem-solving idea has no obvious flaws in logic, risks remain.
  • CD73 is still at a relatively “shallow level”, which can be understood as a low level of verification. I-MAB has to make a last-ditch effort on CD47.
  • At such low market cap, Investors could make an “entertaining bet”. If CD47 is successful, you can earn several times. If not, then admit the defeat.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Japan: Keisei Electric Railway Co, Baycurrent Consulting, Toshiba Corp, Oriental Land, Komatsu Ltd, Tokyo Stock Exchange Tokyo Price Index Topix and more

By | Daily Briefs, Japan

In today’s briefing:

  • StubWorld: Mickey Upstages Keisei Electric
  • MSCI Feb 2023 QCIR Preview: Potential Changes as Review Period Ends
  • Toshiba (6502) – Funding Mostly Secured, Still, Again, Maybe. Or Maybe Not. Or Not.
  • Oriental Land: Fantasy Springs Is No Longer on Management’s Interest
  • Toshiba (6502 JP): Financing Deadline Slips Again as the 3Q Update Looms
  • Komatsu (6301) | Plenty of Gas in the Tank
  • Board Independence Is Demonstrated by Whether It Is Aligned with Common Shareholder Goal

StubWorld: Mickey Upstages Keisei Electric

By David Blennerhassett

  • Keisei Electric Railway Co (9009 JP) is trading “cheap” as Oriental Land (4661 JP) enjoys a zero-Covid revival.
  • Preceding my comments on Keisei/Oriental Land, are the current setup/unwind tables for Asia-Pacific Holdcos. 
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

MSCI Feb 2023 QCIR Preview: Potential Changes as Review Period Ends

By Brian Freitas

  • The review period for the February Quarterly Comprehensive Index Review (QCIR) of the MSCI indices ended yesterday. There will be a number of changes in the Asia Pacific region.
  • Most of the inclusions are in China and the country weight in the MSCI Emerging Markets Index should increase leading to outflows from other markets.
  • On average, the potential adds have outperformed the potential deletes over the last few weeks. At a glance, pre-positioning appears to be lighter than in the past.

Toshiba (6502) – Funding Mostly Secured, Still, Again, Maybe. Or Maybe Not. Or Not.

By Travis Lundy

  • The original bid was supposed to be presented fully-funded by 30 September 2022. Then it was early November, then late November, then early December, late Dec, early Jan, end Jan. 
  • Today we find out that The Banks and The Preferred JIP Bidding Consortium will aim to reach agreement by 3 Feb. The Bloomberg article details are newish, and odd. 
  • Shares have deteriorated and vs Peers, they are at their lowest point in many months. And the details do not make me confident this deal is clean yet. 

Oriental Land: Fantasy Springs Is No Longer on Management’s Interest

By Oshadhi Kumarasiri

  • Aided by the Japanese Government’s efforts to rebuild the COVID-ravaged leisure sector, Oriental Land (4661 JP)’s 3QFY23 OP surpassed consensus by more than 35%.
  • We believe 3QFY23 could be a peak in terms of financial performance for Oriental Land, at least until the opening of the Fantasy Springs.
  • In addition, the growth story that OLC offered through the expansion of DisneySea, seems to be no longer compelling as the management has simply stopped talking about its progress.

Toshiba (6502 JP): Financing Deadline Slips Again as the 3Q Update Looms

By Arun George

  • Bloomberg reports that Japan Industrial Partners (JIP), the preferred bidder, has again extended the deadline for securing bank financing of around JPY1.2 trillion (US$8.8 billion).
  • A new issue has pushed the deadline to 3 February. If JIP manages to secure financing for an offer of around JPY5,100, the next challenge is securing Board support.
  • The 3QFY2022 update on 14 February needs to avoid further downgrades to keep the deal alive. Toshiba’s multiples are unattractive to peers. Remain on the sidelines for now.

Komatsu (6301) | Plenty of Gas in the Tank

By Mark Chadwick

  • Komatsu Q3 operating profit rose 54% YoY, beating analyst estimates by around 12%
  • Construction and Mining Equipment sales rose 31% in the quarter, or ~10% on a constant currency basis versus industry volume of -6%
  • Komatsu shares have sharply lagged the recovery at CAT. We still see significant upside with current P/B of 1.2x

Board Independence Is Demonstrated by Whether It Is Aligned with Common Shareholder Goal

By Aki Matsumoto

  • While shareholder proposals, including those from activist investors, should be considered from independent perspective, it’s clear that even companies with high-% independent directors don’t necessarily get along with activist investors.
  • Board independence is not a question of the number or ratio of independent directors; rather, it is a question of whether independent directors are truly functioning on the board.
  • If the loss of cash results in missed investment opportunities to expand corporate value, this would conflict with interests of shareholders, so subsequent increases in market capitalization should be verified.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Most Read: Adani Transmission, PolyNovo Ltd, Adani Enterprises, Qingdao Haier Biomedical, Keisei Electric Railway Co, Osstem Implant, Baycurrent Consulting, Toshiba Corp, Sembcorp Marine, Flight Centre Travel and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Adani Group: Hindenburg Report Spurs MSCI to Invite Feedback
  • S&P/​​​​​​ASX Index Rebalance Preview: High Impact Changes in March
  • Adani Ent FPO – Early Demand Muted, Adani & Hindenburg Trade Barbs Again, But Not a Good Look
  • STAR50 Index Rebalance Preview: 5 Changes Forecast as Review Period Ends
  • StubWorld: Mickey Upstages Keisei Electric
  • Osstem Implant: Details of Tender Offer & Chairman Choi’s Children Exchange CB Call Options for BWs
  • MSCI Feb 2023 QCIR Preview: Potential Changes as Review Period Ends
  • Toshiba (6502) – Funding Mostly Secured, Still, Again, Maybe. Or Maybe Not. Or Not.
  • Sembcorp Marine-Keppel O&M Merger Circular Squeaks In Under The Wire – Next Steps
  • Flight Centre Travel Group Placement – Still a Good Deal Despite Its Track Record

Adani Group: Hindenburg Report Spurs MSCI to Invite Feedback

By Brian Freitas

  • The Adani Group stocks have taken a dive following the Hindenburg Research report. Group market cap is down more than US$47bn with company promoters taking the biggest hit.
  • The Adani Enterprises FPO is almost certain to be undersubscribed. MSCI, in an unprecedented step, is monitoring publicly available information and is seeking feedback from the investment community.
  • We find that the real float of some Adani Group stocks is much lower than the headline numbers and there could be selling if MSCI lowers the FIF.

S&P/​​​​​​ASX Index Rebalance Preview: High Impact Changes in March

By Brian Freitas

  • We currently see 1 change for the ASX20, 2 for the ASX100, 4 changes for the ASX 200 and 9 adds/ 6 deletes for the ASX300 Index in March.
  • Passive trackers will need to trade over 3 days of ADV on 13 stocks, over 5 days of ADV on 9 stocks and over 10x ADV on 4 stocks. 
  • Shorts have been covering positions on stocks where there are expected to be passive inflows and increasing positions on stocks that are expected to have passive outflows.

Adani Ent FPO – Early Demand Muted, Adani & Hindenburg Trade Barbs Again, But Not a Good Look

By Travis Lundy

  • The Adani Enterprises (ADE IN) FPO saw VERY muted demand (realtime available on NSE+BSE websites) on Day 1 Friday as the share price plummeted through the bottom of the range.
  • The Adani Group responded to Hindenburg late Sunday with a 400-page rebuttal, cloaked in nationalistic terms. Hindenburg responded saying the company failed to answer 62 of 88 questions.
  • This is not going away. They could lower the FPO price, or just pull the FPO. That won’t materially change the significant over-valuation of many Adani Group listco share prices.

STAR50 Index Rebalance Preview: 5 Changes Forecast as Review Period Ends

By Brian Freitas

  • The review period for the March rebalance ends today. We forecast 2 changes using a 12-month minimum listing history, and 5 changes using a 6-month minimum listing history.
  • We expect the index committee to continue using a 6-month minimum listing history. The impact on the potential deletes is a lot higher than the impact on the potential adds.
  • With 5 changes to the index, estimated one-way turnover is 5.1% resulting in a one-way trade of CNY 4,549m. There is a reasonably large reverse funding trade.

StubWorld: Mickey Upstages Keisei Electric

By David Blennerhassett

  • Keisei Electric Railway Co (9009 JP) is trading “cheap” as Oriental Land (4661 JP) enjoys a zero-Covid revival.
  • Preceding my comments on Keisei/Oriental Land, are the current setup/unwind tables for Asia-Pacific Holdcos. 
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

Osstem Implant: Details of Tender Offer & Chairman Choi’s Children Exchange CB Call Options for BWs

By Douglas Kim

  • We provide details of the Osstem Implant tender offer as well as Chairman Choi’s children exchange of CB call options for BWs. 
  • We believe that the majority of the minority shareholders in Osstem Implant are not likely to sell their shares at 190,000 won per share but hold on to it. 
  • Over a longer time frame, Osstem’s share price could reach higher levels driven by its improving sales and profit growth, deep valuation discount to global peers, and further M&A fight. 

MSCI Feb 2023 QCIR Preview: Potential Changes as Review Period Ends

By Brian Freitas

  • The review period for the February Quarterly Comprehensive Index Review (QCIR) of the MSCI indices ended yesterday. There will be a number of changes in the Asia Pacific region.
  • Most of the inclusions are in China and the country weight in the MSCI Emerging Markets Index should increase leading to outflows from other markets.
  • On average, the potential adds have outperformed the potential deletes over the last few weeks. At a glance, pre-positioning appears to be lighter than in the past.

Toshiba (6502) – Funding Mostly Secured, Still, Again, Maybe. Or Maybe Not. Or Not.

By Travis Lundy

  • The original bid was supposed to be presented fully-funded by 30 September 2022. Then it was early November, then late November, then early December, late Dec, early Jan, end Jan. 
  • Today we find out that The Banks and The Preferred JIP Bidding Consortium will aim to reach agreement by 3 Feb. The Bloomberg article details are newish, and odd. 
  • Shares have deteriorated and vs Peers, they are at their lowest point in many months. And the details do not make me confident this deal is clean yet. 

Sembcorp Marine-Keppel O&M Merger Circular Squeaks In Under The Wire – Next Steps

By Travis Lundy

  • Last Friday, Sembcorp Marine (SMM SP) announced it had Approval-In-Principle for its Proposed Combination with Keppel Corp (KEP SP), contingent on the Circular being despatched by 31 January 2023.  
  • At 6:50pm local time on 31 January, Sembcorp Marine released its 679-page Circular (and EGM Announcement (16 Feb EGM)). Phew! 
  • Now we have a deal in sight, we have to think about next steps. SMM NEWCO needs a story vs flow. Orderbook is nice but may not cut it near-term.

Flight Centre Travel Group Placement – Still a Good Deal Despite Its Track Record

By Ethan Aw

  • Flight Centre Travel (FLT AU) is looking to raise US$127m from a fully underwritten institutional placement. 
  • The proceeds will be used to acquire Luxury Travel Holdings (Scott Dunn), a UK-based luxury travel business.
  • In this note, we will discuss deal dynamics, past deal performance, and share the scores on our ECM framework.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Energy/Materials: MMP Industries, Alcoa Inc, Nucor Corp, Vedanta Resources and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • MMP Industries: Forensic Analysis
  • Alcoa Corp: New Brazil Facility & Other Developments
  • Nucor Corp: Launch Of Elcyon & Other Developments
  • Morning Views Asia: JSW Infrastructure, Road King Infrastructure, UPL Ltd, Vedanta Resources

MMP Industries: Forensic Analysis

By Nitin Mangal

  • MMP Industries (MMP IN)  is mainly engaged in the business of manufacturing, selling and distribution and trading of aluminum products such as powder, pyro and flake, paste, foils etc.
  • The company has been on the main board of NSE since F20 but however, its financials are plagued with several forensic concerns.
  • We highlight takeaways mainly related to negative cash flows and their misrepresentation in reporting standards. Additionally, the company is also engaged in various secretarial audit woes.

Alcoa Corp: New Brazil Facility & Other Developments

By Baptista Research

  • Alcoa made progress in 2022 with strategic capacity restarts and efforts to lessen the effects of high energy prices.
  • Global events impacted the price of energy and raw commodities.
  • The company successfully finished the safe restart of its Portland Aluminum Joint Venture smelter in the Australian state of Victoria.

Nucor Corp: Launch Of Elcyon & Other Developments

By Baptista Research

  • Nucor had a mediocre quarter as its earnings dropped compared to the previous two quarters due to reduced shipping volumes and metal margin contraction, particularly at the company’s plate and sheet mills.
  • The startup and construction of the company’s Nucor Stell Brandenburg mill continue progressing incredibly great with respect to schedule, budget, and safety.
  • Lastly, at the end of this quarter, the company announced the approval of the construction of the galvanizing line at its Nucor Steel Berkeley mill.

Morning Views Asia: JSW Infrastructure, Road King Infrastructure, UPL Ltd, Vedanta Resources

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief TMT/Internet: Delta Electronics, GoTo, Hon Hai Precision Industry, Taiwan Semiconductor (TSMC) – ADR, Harvest Technology Group Ltd and more

By | Daily Briefs, TMT/Internet

In today’s briefing:

  • Delta Taiwan Vs. Thailand Monitor: SET50 Re-Inclusion Surge, Biggest Diversion in History
  • GoTo: Going Gets Tough
  • Hon Hai 4Q22 Results Preview: Brace for a Weak Print, But EV Structural Driver Intact
  • Taiwan Tech Weekly: Samsung Results; Will Bleed Competitors; Japan & Holland Join China Chip Ban
  • Harvest Technology Group Limited – Sales Moving up the Curve

Delta Taiwan Vs. Thailand Monitor: SET50 Re-Inclusion Surge, Biggest Diversion in History

By Vincent Fernando, CFA

  • Delta Thailand has surged post SET50 re-inclusion and the stock has dramatically outperformed both Delta Taiwan and Thailand’s SET Index.
  • For both stocks, forward growth rates are expected to be similar for 2023E and 2024E.
  • Delta Taiwan’s stake in Delta Thailand alone is now worth nearly 90% of its market cap.

GoTo: Going Gets Tough

By Shifara Samsudeen, ACMA, CGMA

  • GoTo’s share price lost more than 75% last year following its weaker-than-expected performance and lock-up expiry despite the company entering into a coordinated secondary offering of shares with pre-IPO shareholders.
  • The company’s share price has moved up 24% YTD partially driven by cost cutting measures that is expected to improve the company’s profitability.
  • Nevertheless, we expect this share price rebound to be temporary with e-commerce and food delivery market in Indonesia slowing down.

Hon Hai 4Q22 Results Preview: Brace for a Weak Print, But EV Structural Driver Intact

By Vincent Fernando, CFA

  • Hon Hai’s upcoming results date hasn’t yet been publicly announced, but last year it was 16 March.
  • Gross margin could come in well below consensus, and net profit could be minimal for 4Q22E. Look for reiteration of its longer-term margin target from management.
  • We remain structurally bullish on Hon Hai and see it as positioned favorably relative to U.S. China semiconductor restrictions. Our TP for Hon Hai is $155, over 50% above today.

Taiwan Tech Weekly: Samsung Results; Will Bleed Competitors; Japan & Holland Join China Chip Ban

By Vincent Fernando, CFA

  • Samsung reported 4Q22 detailed results – Semiconductor earnings evaporated and its memory subsegment likely lost money.
  • Samsung re-iterated that it would NOT cut capex despite the market downturn – Samsung appears ready to endure losses which is negative for Nanya Tech, SK Hynix, and Micron.
  • Japan and the Netherlands have joined the U.S. with chip technology restrictions for China – Hon Hai is a net winner.

Harvest Technology Group Limited – Sales Moving up the Curve

By Research as a Service (RaaS)

  • Harvest Technology Group Limited (ASX:HTG) licenses its proprietary video compression and encryption technology for low-bandwidth, high-latency applications needing secure real-time streaming video communication.
  • The company delivers solutions for data transfer from anywhere via satellite or congested networks.
  • Harvest offers a solution which enables real-time monitoring of remote locations, real-time feedback for field technicians, and secure video conferencing. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Consumer: Flight Centre Travel, Oriental Land, Tesla Motors, Ace Hardware Indonesia, Autogrill SpA, Lemon Tree Hotels Ltd, Melco Resorts & Entertainment, S&P 500, Spotify, Tokyo Stock Exchange Tokyo Price Index Topix and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Flight Centre Travel Group Placement – Still a Good Deal Despite Its Track Record
  • Oriental Land: Fantasy Springs Is No Longer on Management’s Interest
  • Tesla’s Demand Problems Aren’t Going Away
  • Ace Hardware Indonesia (ACES IJ) – Will Expansion Mode Be Enough?
  • Dufry/Autogrill: Deal Progress
  • Lemon Tree Hotels Ltd- Forensic Analysis
  • Melco Resorts – Tear Sheet – Lucror Analytics
  • Many Indexes/Sectors Testing Resistance; Limited Upside From Here; Buys in Staples and Health Care
  • Spotify 4Q22: Speed + Efficiency?
  • Board Independence Is Demonstrated by Whether It Is Aligned with Common Shareholder Goal

Flight Centre Travel Group Placement – Still a Good Deal Despite Its Track Record

By Ethan Aw

  • Flight Centre Travel (FLT AU) is looking to raise US$127m from a fully underwritten institutional placement. 
  • The proceeds will be used to acquire Luxury Travel Holdings (Scott Dunn), a UK-based luxury travel business.
  • In this note, we will discuss deal dynamics, past deal performance, and share the scores on our ECM framework.

Oriental Land: Fantasy Springs Is No Longer on Management’s Interest

By Oshadhi Kumarasiri

  • Aided by the Japanese Government’s efforts to rebuild the COVID-ravaged leisure sector, Oriental Land (4661 JP)’s 3QFY23 OP surpassed consensus by more than 35%.
  • We believe 3QFY23 could be a peak in terms of financial performance for Oriental Land, at least until the opening of the Fantasy Springs.
  • In addition, the growth story that OLC offered through the expansion of DisneySea, seems to be no longer compelling as the management has simply stopped talking about its progress.

Tesla’s Demand Problems Aren’t Going Away

By Vicki Bryan

  • The market says Tesla’s 20-30% price cuts will reverse stalling demand, even though several rounds of expensive cuts & incentives in Q4 didn’t.
  • I’m not convinced, as shown in my 2023 model & forecast.
  • Tesla apparently isn’t either, as indicated by sharply lower guidance and apparently plans to ramp up debt to bolster cash.

Ace Hardware Indonesia (ACES IJ) – Will Expansion Mode Be Enough?

By Angus Mackintosh

  • Ace Hardware has been a distinct laggard amongst listed retailers in Indonesia, with its valuations drifting to multi-year lows, given a slow recovery from the pandemic and limited digital strategy. 
  • The company has continued to see lacklustre SSSG finish flat for last year but has recently opined a more optimistic outlook for 2023, planning to open 10-15 new stores.
  • Ace Hardware Indonesia (ACES IJ) trades on 13.7x FY2023E PER and 12.7x FY2024E PER when it used to trade on twice that multiple with not dissimilar growth rates.

Dufry/Autogrill: Deal Progress

By Jesus Rodriguez Aguilar

  • The deal is done with the transfer of Edizione’s 50.3% stake in Autogrill under way, and with  all main hurdles cleared. Dufry must launch and offer to buy out minorities. 
  • Autogrill shares closed at €6.698 on 30 January, also the implied value of the 0.158 Autogrill/Dufry share swap is 5.8% above the €6.33/share “initial” cash offer. The market expects more.
  • The deal will not fall through but the price is still being negotiated, possibly around €6.8-6.9/share. The issue will now become what dilution/leverage will Dufry’s patient shareholders endure.

Lemon Tree Hotels Ltd- Forensic Analysis

By Nitin Mangal

  • Lemon Tree Hotels Ltd (LEMONTRE IN) (“LTHL”) is India’s largest mid-market hotel chain with 7 brands and 87 properties across 54 destinations and 8,489 rooms as at F22.
  • We noticed few setbacks on the forensics, particularly with respect to impairment in subsidiary and unusual accounting with revaluation of PPE.
  • While the operations have seen a revival in terms of ARR and margins, LTHL however is yet to reach occupancy levels of pre-covid.

Melco Resorts – Tear Sheet – Lucror Analytics

By Leonard Law, CFA

We view Melco Resorts (MLCO) as “Medium Risk” on the LARA scale. The company has a sound market position in Macau through its core assets, City of Dreams (COD) Macau and Studio City. Our view takes into account MLCO’s: [1] solid execution track record; [2] satisfactory capital management; and [3] geographical and asset diversification, with six assets. This is balanced against the company’s weakened financial profile owing to the COVID-19 crisis, as well as event risks arising from its expansion plans.

Our fundamental Credit Bias on MLCO is “Negative”, as we expect the company’s FCF to remain negative in H1/23, due to capex for the development of Studio City Phase 2. We view unfavourably MLCO’s small share repurchases despite its ongoing operating cash burn. Positively, the company has a strong liquidity profile, with a robust cash position. It should begin to deleverage from H2, after the COD Mediterranean and Studio City Phase 2 developments have been completed. 

Controversies are “Immaterial”. Some ESG-compliant funds may be prohibited from investing in MLCO, due to the nature of its core business (casinos). That said, Macau’s gaming industry is established, transparent and highly regulated. We believe the curtailment of junket activities would help to further raise operators’ transparency. Moreover, the authorities are seeking to reduce the city’s reliance on gaming and promote leisure tourism in the medium term. These factors should mitigate ESG-related risks. Overall, the ESG Impact on Credit is “Neutral”.


Many Indexes/Sectors Testing Resistance; Limited Upside From Here; Buys in Staples and Health Care

By Joe Jasper

  • We previously discussed our belief that equities were in the midst of a rally/short squeeze, but that the rally is likely to fizzle in the 4100-4165 area on S&P 500
  • And, as you will see below, countless other indexes and Sectors are testing important resistance levels. We continue to expect 4100-4165 on the S&P 500 to cap upside
  • Buy ideas highlighted within defensives, including Consumer Staples, Health Care, and Communications: CMCSA, CHTR, UL, KHC, CAG, SJM, CPB, LLY, MRK, and NVO

Spotify 4Q22: Speed + Efficiency?

By Aaron Gabin

  • Management promises belt tightening! Losing €659M at ~€12B in revenues? And still won’t be profitable in 2023?  Why should investors believe this change?
  • Gross margin guidance misses…again. Two beats in the past 3 years on gross margins.
  • Podcasting growing 100% in 1Q22 exited 4Q22 growing 30%…and ad-related revenues still just 14% of the total. Why will this move the needle?

Board Independence Is Demonstrated by Whether It Is Aligned with Common Shareholder Goal

By Aki Matsumoto

  • While shareholder proposals, including those from activist investors, should be considered from independent perspective, it’s clear that even companies with high-% independent directors don’t necessarily get along with activist investors.
  • Board independence is not a question of the number or ratio of independent directors; rather, it is a question of whether independent directors are truly functioning on the board.
  • If the loss of cash results in missed investment opportunities to expand corporate value, this would conflict with interests of shareholders, so subsequent increases in market capitalization should be verified.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Keisei Electric Railway Co, Baycurrent Consulting, Toshiba Corp, Sembcorp Marine, Komatsu Ltd and more

By | Daily Briefs, Industrials

In today’s briefing:

  • StubWorld: Mickey Upstages Keisei Electric
  • MSCI Feb 2023 QCIR Preview: Potential Changes as Review Period Ends
  • Toshiba (6502) – Funding Mostly Secured, Still, Again, Maybe. Or Maybe Not. Or Not.
  • Sembcorp Marine-Keppel O&M Merger Circular Squeaks In Under The Wire – Next Steps
  • Toshiba (6502 JP): Financing Deadline Slips Again as the 3Q Update Looms
  • Komatsu (6301) | Plenty of Gas in the Tank

StubWorld: Mickey Upstages Keisei Electric

By David Blennerhassett

  • Keisei Electric Railway Co (9009 JP) is trading “cheap” as Oriental Land (4661 JP) enjoys a zero-Covid revival.
  • Preceding my comments on Keisei/Oriental Land, are the current setup/unwind tables for Asia-Pacific Holdcos. 
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

MSCI Feb 2023 QCIR Preview: Potential Changes as Review Period Ends

By Brian Freitas

  • The review period for the February Quarterly Comprehensive Index Review (QCIR) of the MSCI indices ended yesterday. There will be a number of changes in the Asia Pacific region.
  • Most of the inclusions are in China and the country weight in the MSCI Emerging Markets Index should increase leading to outflows from other markets.
  • On average, the potential adds have outperformed the potential deletes over the last few weeks. At a glance, pre-positioning appears to be lighter than in the past.

Toshiba (6502) – Funding Mostly Secured, Still, Again, Maybe. Or Maybe Not. Or Not.

By Travis Lundy

  • The original bid was supposed to be presented fully-funded by 30 September 2022. Then it was early November, then late November, then early December, late Dec, early Jan, end Jan. 
  • Today we find out that The Banks and The Preferred JIP Bidding Consortium will aim to reach agreement by 3 Feb. The Bloomberg article details are newish, and odd. 
  • Shares have deteriorated and vs Peers, they are at their lowest point in many months. And the details do not make me confident this deal is clean yet. 

Sembcorp Marine-Keppel O&M Merger Circular Squeaks In Under The Wire – Next Steps

By Travis Lundy

  • Last Friday, Sembcorp Marine (SMM SP) announced it had Approval-In-Principle for its Proposed Combination with Keppel Corp (KEP SP), contingent on the Circular being despatched by 31 January 2023.  
  • At 6:50pm local time on 31 January, Sembcorp Marine released its 679-page Circular (and EGM Announcement (16 Feb EGM)). Phew! 
  • Now we have a deal in sight, we have to think about next steps. SMM NEWCO needs a story vs flow. Orderbook is nice but may not cut it near-term.

Toshiba (6502 JP): Financing Deadline Slips Again as the 3Q Update Looms

By Arun George

  • Bloomberg reports that Japan Industrial Partners (JIP), the preferred bidder, has again extended the deadline for securing bank financing of around JPY1.2 trillion (US$8.8 billion).
  • A new issue has pushed the deadline to 3 February. If JIP manages to secure financing for an offer of around JPY5,100, the next challenge is securing Board support.
  • The 3QFY2022 update on 14 February needs to avoid further downgrades to keep the deal alive. Toshiba’s multiples are unattractive to peers. Remain on the sidelines for now.

Komatsu (6301) | Plenty of Gas in the Tank

By Mark Chadwick

  • Komatsu Q3 operating profit rose 54% YoY, beating analyst estimates by around 12%
  • Construction and Mining Equipment sales rose 31% in the quarter, or ~10% on a constant currency basis versus industry volume of -6%
  • Komatsu shares have sharply lagged the recovery at CAT. We still see significant upside with current P/B of 1.2x

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Industrials: Keisei Electric Railway Co, Baycurrent Consulting, Toshiba Corp, Sembcorp Marine, Komatsu Ltd and more

By | Daily Briefs, Industrials

In today’s briefing:

  • StubWorld: Mickey Upstages Keisei Electric
  • MSCI Feb 2023 QCIR Preview: Potential Changes as Review Period Ends
  • Toshiba (6502) – Funding Mostly Secured, Still, Again, Maybe. Or Maybe Not. Or Not.
  • Sembcorp Marine-Keppel O&M Merger Circular Squeaks In Under The Wire – Next Steps
  • Toshiba (6502 JP): Financing Deadline Slips Again as the 3Q Update Looms
  • Komatsu (6301) | Plenty of Gas in the Tank

StubWorld: Mickey Upstages Keisei Electric

By David Blennerhassett

  • Keisei Electric Railway Co (9009 JP) is trading “cheap” as Oriental Land (4661 JP) enjoys a zero-Covid revival.
  • Preceding my comments on Keisei/Oriental Land, are the current setup/unwind tables for Asia-Pacific Holdcos. 
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

MSCI Feb 2023 QCIR Preview: Potential Changes as Review Period Ends

By Brian Freitas

  • The review period for the February Quarterly Comprehensive Index Review (QCIR) of the MSCI indices ended yesterday. There will be a number of changes in the Asia Pacific region.
  • Most of the inclusions are in China and the country weight in the MSCI Emerging Markets Index should increase leading to outflows from other markets.
  • On average, the potential adds have outperformed the potential deletes over the last few weeks. At a glance, pre-positioning appears to be lighter than in the past.

Toshiba (6502) – Funding Mostly Secured, Still, Again, Maybe. Or Maybe Not. Or Not.

By Travis Lundy

  • The original bid was supposed to be presented fully-funded by 30 September 2022. Then it was early November, then late November, then early December, late Dec, early Jan, end Jan. 
  • Today we find out that The Banks and The Preferred JIP Bidding Consortium will aim to reach agreement by 3 Feb. The Bloomberg article details are newish, and odd. 
  • Shares have deteriorated and vs Peers, they are at their lowest point in many months. And the details do not make me confident this deal is clean yet. 

Sembcorp Marine-Keppel O&M Merger Circular Squeaks In Under The Wire – Next Steps

By Travis Lundy

  • Last Friday, Sembcorp Marine (SMM SP) announced it had Approval-In-Principle for its Proposed Combination with Keppel Corp (KEP SP), contingent on the Circular being despatched by 31 January 2023.  
  • At 6:50pm local time on 31 January, Sembcorp Marine released its 679-page Circular (and EGM Announcement (16 Feb EGM)). Phew! 
  • Now we have a deal in sight, we have to think about next steps. SMM NEWCO needs a story vs flow. Orderbook is nice but may not cut it near-term.

Toshiba (6502 JP): Financing Deadline Slips Again as the 3Q Update Looms

By Arun George

  • Bloomberg reports that Japan Industrial Partners (JIP), the preferred bidder, has again extended the deadline for securing bank financing of around JPY1.2 trillion (US$8.8 billion).
  • A new issue has pushed the deadline to 3 February. If JIP manages to secure financing for an offer of around JPY5,100, the next challenge is securing Board support.
  • The 3QFY2022 update on 14 February needs to avoid further downgrades to keep the deal alive. Toshiba’s multiples are unattractive to peers. Remain on the sidelines for now.

Komatsu (6301) | Plenty of Gas in the Tank

By Mark Chadwick

  • Komatsu Q3 operating profit rose 54% YoY, beating analyst estimates by around 12%
  • Construction and Mining Equipment sales rose 31% in the quarter, or ~10% on a constant currency basis versus industry volume of -6%
  • Komatsu shares have sharply lagged the recovery at CAT. We still see significant upside with current P/B of 1.2x

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Health Care: Samsung Biologics, Context Therapeutics, I-Mab and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Samsung Biologics (207940 KS): 2022 Revenue Surpassed KRW3T; Strong Growth Momentum to Continue
  • Context Therapeutics – Elacestrant approval shot in the arm for ELONA trial
  • I-Mab (IMAB.US) – An “Entertaining Bet”: To Be a Dark Horse or to Fail Completely

Samsung Biologics (207940 KS): 2022 Revenue Surpassed KRW3T; Strong Growth Momentum to Continue

By Tina Banerjee

  • In 2022, Samsung Biologics (207940 KS) posted record-high consolidated revenue of KRW3 trillion and, driven by new orders, efficient plant utilization, and inclusion of Samsung Bioepis as a wholly-owned subsidiary.
  • Plant 4 is on track to be completed in H12023, with active pre-sale activities are rapidly locking in capacity. Strong order momentum continued, with 2022 CMO contract amount of $9.5B.
  • Samsung Bioepis reported revenue growth of 12% to KRW946B, driven by stable sales of existing products and new product launch. Humira biosimilar launch in the US is the biggest catalyst.

Context Therapeutics – Elacestrant approval shot in the arm for ELONA trial

By Edison Investment Research

On 27 January, the US FDA approved Stemline Therapeutics’ (wholly owned US subsidiary of the Menarini group) elacestrant (Orserdu) as second-line treatment for ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer (mBC), making it the first oral selective estrogen receptor degrader (SERD) to be approved for the indication and the first-ever approved drug for cases with the ESR1 mutation (~40%of all cases in this category). We see this as a material development for Context Therapeutics, which is currently undertaking Phase Ib trials (ELONA trial in collaboration with Menarini) for its drug ONA-XR in combination with elacestrant for the treatment of second/third-line HR+/HER2- mBC. ONA-XR has previously shown promising preclinical data in combination with anti-estrogen therapy, and improved efficacy, if demonstrated in the ELONA trial, should open the door for partnering prospects and create significant market opportunity for Context, in our opinion.


I-Mab (IMAB.US) – An “Entertaining Bet”: To Be a Dark Horse or to Fail Completely

By Xinyao (Criss) Wang

  • Many people aren’t optimistic about CD47 because there is no sufficient evidence to solve blood toxicity. Although I-MAB’s problem-solving idea has no obvious flaws in logic, risks remain.
  • CD73 is still at a relatively “shallow level”, which can be understood as a low level of verification. I-MAB has to make a last-ditch effort on CD47.
  • At such low market cap, Investors could make an “entertaining bet”. If CD47 is successful, you can earn several times. If not, then admit the defeat.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars

Daily Brief Financials: Bank Mandiri Persero, Siam Commercial Bank, Bandhan Bank Ltd, Sorare and more

By | Daily Briefs, Financials

In today’s briefing:

  • Bank Mandiri (BMRI IJ) – Brimming with Convenience and Returns
  • Siam Commercial Bank (SCB TB) – Traversing Generations
  • Bandhan Bank | The Road Ahead
  • Sporting Crypto – Sorare Announce £30m Per-Year Blockbuster Premier League Deal

Bank Mandiri (BMRI IJ) – Brimming with Convenience and Returns

By Angus Mackintosh

  • Bank Mandiri (BMRI IJ) finished the year with a strong showing of loan growth across the board driven by corporate and commercial loans but micro was also a feature. 
  • Both the bank’s consumer app under Livin’ and its digital corporate platform under Kopra continue to help drive CASA growth and transactions plus the bank is opening “smart” branches. 
  • Bank Mandiri (BMRI IJ) is optimistic about the outlook for loan growth and NIMs in 2023, with its digital initiatives continuing to gain traction and drive growth. Valuations are attractive.

Siam Commercial Bank (SCB TB) – Traversing Generations

By Angus Mackintosh

  • Siam Commercial Bank (SCB TB) booked a solid set of 4Q2022 results, with the first NIM expansion in two years and record high net interest income.
  • The bank also provided details of its mothership strategy, which has now come to fruition, with the restructuring process now complete with its increasingly strong digital credentials becoming clearer.
  • Siam Commercial Bank remains attractive on valuations and probably deserves to trade at a premium to peers given its digital credentials but more data may be required to get there.

Bandhan Bank | The Road Ahead

By Pranav Bhavsar

  • Bandhan Bank Ltd (BANDHAN IN) reported weak earnings with a flat (-2%) Net Interest Income growth and a +91 YoY growth in provisions.
  • Additional slippage continues to come primarily from the EEB portfolio. The overall advances recorded is 14% YoY growth driven by the Retail segment, including housing and MSME.
  • Improvement in customer behaviour in terms of regularizing accounts is a critical component that needs to be verified and checked for the bank to move ahead.

Sporting Crypto – Sorare Announce £30m Per-Year Blockbuster Premier League Deal

By Sporting Crypto

  • At long last — after months of rumours — Sorare and the English Premier League (EPL) have finally announced their exclusive multi-year deal thought to be worth £30m per year.
  • For Sorare, this was the final piece to the puzzle. That final big deal in Soccer that they wanted to get over the line.
  • Just over 4 years from inception, they now have deals in place with almost every top flight club and league in the world.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars